Cornerstone Wealth Group’s Boston Scientific BSX Stock Holding History

Cornerstone Wealth Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Sell	5,051 -59,182	-92%	-$3.21M	0.01%	465
2026 Q1	$3.82M	Buy	64,233 +59,722	+1,324%	+$4.78M	0.25%	103
2025 Q4	$430K	Buy	4,511 +470	+12%	+$46.1K	0.03%	225
2025 Q3	$395K	Buy	4,041 +203	+5%	+$21K	0.03%	226
2025 Q2	$412K	Buy	3,838 +809	+27%	+$81.9K	0.03%	206
2025 Q1	$306K	Buy	3,029 +267	+10%	+$26.9K	0.03%	221
2024 Q4	$247K	Buy	2,762 +205	+8%	+$18K	0.02%	238
2024 Q3	$214K	Sell	2,557 -132	-5%	-$10.4K	0.02%	245
2024 Q2	$207K	Buy	+2,689	New	+$197K	0.02%	239
2021 Q4	–	Sell	-108,777	Closed	-$4.72M	–	151
2021 Q3	$4.72M	Buy	+108,777	New	+$4.81M	0.83%	29

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cornerstone Wealth Group's BSX Position: Q2 2026 in Review

Cornerstone Wealth Group reduced its Boston Scientific (BSX) stake by 92% in Q2 2026, selling an estimated $3.21M and leaving 5,051 shares worth $216K. The position accounts for 0.01% of the portfolio, ranked #465.

Cornerstone Wealth Group first reported a position in BSX in Q3 2021 and has held it in 10 quarters since. The position peaked at $4.72M in Q3 2021. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Cornerstone Wealth Group held 5,051 shares of Boston Scientific worth $216K as of Q2 2026.
Cornerstone Wealth Group sold 59,182 Boston Scientific shares in Q2 2026, an estimated $3.21M.
Boston Scientific made up 0.01% of Cornerstone Wealth Group's portfolio in Q2 2026, its #465 holding.
Cornerstone Wealth Group first reported a position in Boston Scientific in Q3 2021 and has held it in 10 quarters since.
Cornerstone Wealth Group's Boston Scientific position peaked at $4.72M in Q3 2021.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cornerstone Wealth Group's 13F filing for Q2 2026, filed 27 Jul 2026.